norgestrel has been researched along with medroxyprogesterone acetate in 56 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 30 (53.57) | 18.7374 |
1990's | 14 (25.00) | 18.2507 |
2000's | 10 (17.86) | 29.6817 |
2010's | 2 (3.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Keisler, LW; Kier, AB; Walker, SE | 1 |
Edgren, RA | 1 |
Anderson, DC; Buckler, HM; Burger, HG; Evans, CA; Mamtora, H | 1 |
Cassidenti, DL; Lobo, RA; Paulson, RJ; Serafini, P; Stanczyk, FZ | 1 |
LaRosa, JC; Miller, VT; Muesing, RA; Phillips, EA; Stillman, RJ; Stoy, DB | 1 |
Kamau, RK; Kigondu, C; Maina, FW; Mati, JK | 1 |
Laird, M; Monier, M | 1 |
Florio, V; Morini, A; Mossa, B; Roscetti, C | 1 |
Mishell, DR | 1 |
Ayeni, O; Chalapati, S; Crawford, MA; Drury, PJ; Dusitsin, N; Gellen, JJ; Lenihan, T; Pinol, A; Sas, M; Tunkeyoon, M | 1 |
Keller, PJ | 1 |
Heng, SH; Liew, DF; Ng, CS; Ratnam, SS | 1 |
Fotherby, K | 1 |
King, RJ; Whitehead, MI | 1 |
Odlind, V | 1 |
Fraser, IS | 1 |
Hirvonen, E; Kärkkäinen, J; Lipasti, A; Mälkönen, M; Manninen, V; Nuntila, J; Timonen, H | 1 |
Okada, H | 1 |
Belsey, EM | 2 |
Belsey, EM; Peregoudov, S | 1 |
Belsey, EM; Carlson, N; d'Arcangues, C | 1 |
von Schoultz, B | 1 |
Conti, G; Di Carlo, F; Gallo, E; Racca, S | 1 |
Boots, LR; Bradley, EL; Cornwell, PE; Donahue, MA | 1 |
Ayeni, O; Chalapati, S; Dusitsin, N; Gellen, JJ; Gray, R; Koetsawang, S; Pinol, A; Saibiang, S; Sas, M; Tankeyoon, M | 1 |
Babu, S; Prema, K; Ramalakshmi, BA | 1 |
Gustafson, A; Samsioe, G; Silfverstolpe, G; Svanborg, A | 1 |
Lammintausta, R; Punnonen, R; Viinamäki, O | 1 |
Taskinen, MR | 1 |
Oyelola, OO | 1 |
Thomas, EJ | 1 |
Hyder, SM; Murthy, L; Stancel, GM | 1 |
Koval, JJ; Nisker, JA; Wolfe, BM | 2 |
Arteaga, A; Arteaga, E; Bianchi, M; Durán, D; Rojas, A; Villaseca, P | 1 |
Cuadros, JL; Ortega, E; Rodriguez-Alemán, F; Ruiz, E; Torres, JM | 1 |
Applezweig, N | 1 |
Gordon, M; Hemperly, S; Kohorn, EI; Rice, SI | 1 |
Ali, N; Hashmi, JA; Kazi, A; Kazi, AB | 1 |
Prous, JR; Sussmann, AR | 1 |
Rozenbaum, H | 1 |
Caubel, P; Chetrite, GS; Friedman, AJ; Pasqualini, JR; Philippe, JC | 1 |
Knopp, RH; Leboeuf, RC; Rosenfeld, ME; Shultz, JM; Zhu, XD | 1 |
Boerstoel-Streefland, M; Hendricks, PT; Wierik, EJ | 1 |
Levine, JP | 1 |
Szarewski, A | 1 |
Gupta, N | 1 |
Brown, HE; Hammond, N; Roddy, ME; Thurman, AR | 1 |
Atlas, M; Gordon, L; Januchowski, R; Thakur, N | 1 |
Hu, CQ; Jin, SH; Liu, F; Shi, YQ; Yao, J; Yuan, J; Zhang, QM | 1 |
Freeman, S; Shulman, LP | 1 |
Weisberg, E | 1 |
7 review(s) available for norgestrel and medroxyprogesterone acetate
Article | Year |
---|---|
Oral contraception: a review.
Topics: Contraceptives, Oral; Ethynodiol Diacetate; Female; History, 20th Century; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norethynodrel; Norgestrel; Progesterone; United States; United States Food and Drug Administration | 1991 |
[Hormonal contraception using depot preparations].
Topics: Abnormalities, Drug-Induced; Blood Coagulation; Carbohydrate Metabolism; Cardiovascular Diseases; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Infant, Newborn; Levonorgestrel; Liver; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Norethindrone; Norgestrel; Pregnancy; Risk | 1986 |
New delivery systems for hormonal contraception.
Topics: Contraceptive Agents, Female; Drug Implants; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norgestrel; Pregnancy; Progesterone; Progestins; Research; Time Factors; Vagina | 1986 |
Nondaily hormonal contraception: establishing a fit between product characteristics and patient preferences.
Topics: Affect; Contraception; Contraception Behavior; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Desogestrel; Drug Administration Schedule; Drug Combinations; Drug Implants; Ethisterone; Female; Humans; Injections; Levonorgestrel; Medroxyprogesterone Acetate; Norgestrel; Oximes; Patient Education as Topic; Progesterone Congeners; Risk Factors; United States; Weight Gain; Women's Health | 2004 |
Hormonal contraception: recent advances.
Topics: Contraception; Contraceptive Agents, Female; Desogestrel; Drug Combinations; Ethisterone; Female; Humans; Levonorgestrel; Male; Medroxyprogesterone Acetate; Norgestrel; Oximes; Venous Thrombosis; Women's Health | 2006 |
Advances in hormonal contraception.
Topics: Administration, Cutaneous; Administration, Intravaginal; Contraceptive Agents, Female; Contraceptives, Postcoital; Delayed-Action Preparations; Drug Combinations; Ethinyl Estradiol; Female; Humans; Injections, Subcutaneous; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone Acetate; Norgestrel | 2006 |
Considerations for the use of progestin-only contraceptives.
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital; Counseling; Desogestrel; Drug Prescriptions; Family Planning Services; Female; Health Promotion; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Neoplasms; Norethindrone; Norgestrel; Patient Education as Topic; Patient Selection; Pregnancy, Unplanned; Progesterone Congeners; Risk Factors; United States | 2010 |
14 trial(s) available for norgestrel and medroxyprogesterone acetate
Article | Year |
---|---|
Effects of conjugated equine estrogen with and without three different progestogens on lipoproteins, high-density lipoprotein subfractions, and apolipoprotein A-I.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins A; Cholesterol; Cholesterol, HDL; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipoproteins; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Sex Hormone-Binding Globulin | 1991 |
The effect of low-oestrogen combined pill, progestogen-only pill and medroxyprogesterone acetate on oral glucose tolerance test.
Topics: Adult; Contraceptive Agents, Female; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Glucose Tolerance Test; Humans; Hyperglycemia; Hypoglycemia; Kenya; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Norgestrel | 1990 |
[Emergency ambulatory treatment of dysfunctional metrorrhagia in adolescents].
Topics: Adolescent; Ambulatory Care; Drug Combinations; Drug Evaluation; Emergencies; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Metrorrhagia; Norethindrone; Norethindrone Acetate; Norgestrel; Norpregnenes | 1989 |
An investigation on the influence of steroidal contraceptives on milk lipid and fatty acids in Hungary and Thailand. WHO Special Programme of Research, Development and Research Training in Human Reproduction. Task Force on oral contraceptives.
Topics: Contraceptive Agents; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Double-Blind Method; Ethinyl Estradiol; Fatty Acids; Fatty Acids, Essential; Female; Humans; Hungary; Injections; Levonorgestrel; Lipid Metabolism; Medroxyprogesterone; Medroxyprogesterone Acetate; Milk, Human; Norgestrel; Thailand | 1986 |
Clinical and lipid metabolic effects of unopposed oestrogen and two oestrogen-progestogen regimens in post-menopausal women.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Drug Therapy, Combination; Estradiol; Female; Humans; Levonorgestrel; Lipids; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norgestrel; Triglycerides | 1987 |
Vaginal bleeding patterns among women using one natural and eight hormonal methods of contraception.
Topics: Administration, Intravaginal; Clinical Trials as Topic; Contraception; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Medical Records; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Norethindrone; Norethindrone Acetate; Norgestrel; Ovulation Detection; Research Design | 1988 |
The association between vaginal bleeding patterns and reasons for discontinuation of contraceptive use.
Topics: Administration, Intravaginal; Clinical Trials as Topic; Contraceptive Agents; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Menstruation Disturbances; Norgestrel; Patient Compliance; Patient Dropouts | 1988 |
Determinants of menstrual bleeding patterns among women using natural and hormonal methods of contraception. I. Regional variations.
Topics: Administration, Intravaginal; Africa; Asia; China; Clinical Trials as Topic; Contraception; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Europe; Female; Humans; Latin America; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Multicenter Studies as Topic; Norgestrel; West Indies | 1988 |
Effects of hormonal contraceptives on milk volume and infant growth. WHO Special Programme of Research, Development and Research Training in Human Reproduction Task force on oral contraceptives.
Topics: Adult; Body Height; Body Weight; Breast Feeding; Child Development; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Hungary; Infant; Infant, Newborn; Lactation; Levonorgestrel; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Milk, Human; Norgestrel; Pregnancy; Thailand | 1984 |
Fasting plasma lipids, lipoproteins and apolipoproteins in Nigerian women using combined oral and progestin-only injectable contraceptives.
Topics: Adult; Analysis of Variance; Apolipoprotein A-I; Apolipoproteins; Apolipoproteins B; Blood Pressure; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Lipids; Lipoproteins; Medroxyprogesterone Acetate; Nigeria; Norgestrel; Risk Factors | 1993 |
Add-back therapy for long-term use in dysfunctional uterine bleeding and uterine fibroids.
Topics: Adult; Climacteric; Drug Combinations; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Goserelin; Headache; Humans; Leiomyomatosis; Medroxyprogesterone Acetate; Menorrhagia; Middle Aged; Norgestrel; Progestins; Treatment Outcome; Uterine Neoplasms | 1996 |
Effects of adding C-19 versus C-21 progestin to conjugated estrogen in moderately hypercholesterolemic postmenopausal women.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cross-Over Studies; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Hypercholesterolemia; Medroxyprogesterone Acetate; Norgestrel; Postmenopause; Prospective Studies; Triglycerides | 1998 |
Impact on postmenopausal symptoms of adding continuous C-21 versus C-19 progestin to estrogen.
Topics: Adverse Drug Reaction Reporting Systems; Climacteric; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norgestrel; Prospective Studies | 1999 |
Effect of estrogen-progestin replacement therapy on plasma lipids and lipoproteins in postmenopausal women.
Topics: Apolipoprotein A-I; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Estradiol; Estrogen Replacement Therapy; Female; Follicle Stimulating Hormone; Humans; Lipids; Lipoproteins; Luteinizing Hormone; Medroxyprogesterone Acetate; Middle Aged; Norgestrel; Postmenopause; Progesterone; Progestins; Testosterone; Triglycerides | 2000 |
35 other study(ies) available for norgestrel and medroxyprogesterone acetate
Article | Year |
---|---|
Effects of prolonged administration of the 19-nor-testosterone derivatives norethindrone and norgestrel to female NZB/W mice: comparison with medroxyprogesterone and ethinyl estradiol.
Topics: Animals; Antibodies, Antinuclear; Contraceptives, Oral, Hormonal; Disease Models, Animal; Ethinyl Estradiol; Female; Longevity; Lupus Erythematosus, Systemic; Lupus Nephritis; Medroxyprogesterone Acetate; Mice; Mice, Inbred NZB; Norethindrone; Norgestrel; Time Factors; Urinary Tract | 1991 |
Gonadotropin, steroid, and inhibin levels in women with incipient ovarian failure during anovulatory and ovulatory rebound cycles.
Topics: Adult; Anovulation; Desogestrel; Estradiol; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Follicle Stimulating Hormone; Humans; Infertility, Female; Inhibins; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Norgestrel; Norpregnenes; Ovarian Diseases; Ovulation; Progesterone; Progestins | 1991 |
Effects of sex steroids on skin 5 alpha-reductase activity in vitro.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Adult; Dose-Response Relationship, Drug; Estradiol; Ethinyl Estradiol; Female; Humans; In Vitro Techniques; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norgestrel; Progesterone; Skin; Steroids | 1991 |
Contraceptives: a look at the future.
Topics: Abortifacient Agents; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Male; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Implants; Female; Forecasting; Humans; Injections; Levonorgestrel; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Norgestrel; Pregnancy | 1989 |
Use of progestins.
Topics: Cholesterol, HDL; Cholesterol, LDL; Drug Combinations; Estradiol; Estradiol Congeners; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Lipids; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Norgestrel; Progestins; Time Factors | 1989 |
A comparative study of the metabolic effects of injectable and oral contraceptives.
Topics: Adult; Blood Glucose; Cholesterol; Contraceptive Agents, Female; Contraceptives, Oral; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Glucose Tolerance Test; Humans; Insulin; Lipids; Medroxyprogesterone; Medroxyprogesterone Acetate; Norgestrel; Triglycerides | 1986 |
Pharmacokinetics of progestational compounds.
Topics: Absorption; Aged; Blood Proteins; Drug Interactions; Female; Humans; Kinetics; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norgestrel; Osmolar Concentration; Progestins | 1986 |
Assessment of the potency of orally administered progestins in women.
Topics: Administration, Oral; Adult; Age Factors; DNA; Dose-Response Relationship, Drug; Drug Evaluation; Dydrogesterone; Endometrium; Estradiol Dehydrogenases; Female; Glycogen; Humans; Isocitrate Dehydrogenase; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Menstrual Cycle; Middle Aged; Norethindrone; Norgestrel; Progesterone; Progesterone Congeners; Reference Values | 1986 |
Menstrual changes associated with progestogen-only contraception.
Topics: Administration, Oral; Amenorrhea; Contraceptive Agents, Female; Counseling; Estrogens; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Norethindrone; Norgestrel; Time Factors | 1986 |
[Progestogen therapy in the treatment of endometrial cancer--clinical results and mechanism of steroid action].
Topics: Estrenes; Female; Humans; In Vitro Techniques; Medroxyprogesterone; Medroxyprogesterone Acetate; Mifepristone; Neoplasms, Hormone-Dependent; Norethindrone; Norgestrel; Progesterone Congeners; Receptors, Progesterone; Tumor Stem Cell Assay; Uterine Neoplasms | 1988 |
Determinants of menstrual bleeding patterns among women using natural and hormonal methods of contraception. II. The influence of individual characteristics.
Topics: Abortion, Induced; Administration, Intravaginal; Adult; Age Factors; Contraception; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Norgestrel; Parity; Pregnancy; Time Factors | 1988 |
Vasomotor symptoms and estrogen-progestogen therapy.
Topics: Adult; Climacteric; Contraceptives, Oral, Combined; Estradiol; Estriol; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norgestrel; Progesterone; Progestins; Vasomotor System | 1985 |
Changes in the binding of oestradiol to uterine oestrogen receptors induced by some progesterone and 19-nor-testosterone derivatives.
Topics: Animals; Chlormadinone Acetate; Cytoplasm; Estradiol; Female; In Vitro Techniques; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norgestrel; Rats; Receptors, Estradiol; Receptors, Estrogen; Uterus | 1983 |
Vitamin fluctuations in the blood of female baboons in relation to normal menstrual cycles, treatments with Lo-Ovral or Depo-Provera and a selected vitamin supplement.
Topics: Animals; Ascorbic Acid; Carotenoids; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Norgestrel; Papio; Vitamin A; Vitamin B Complex; Vitamins | 1983 |
Long-acting progestins--promise and prospects.
Topics: Animals; Bibliographies as Topic; Breast Neoplasms; Contraceptives, Oral, Combined; Delayed-Action Preparations; Dogs; Female; Haplorhini; Humans; Injections, Intramuscular; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norgestrel; Progesterone Congeners; Rats; Reproduction; Uterine Neoplasms | 1983 |
Serum copper and zinc in hormonal contraceptive users.
Topics: 20-alpha-Dihydroprogesterone; Contraceptive Devices, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Copper; Estradiol; Ethinyl Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norgestrel; Zinc | 1980 |
Lipid metabolic studies in oophorectomized women: effects of synthetic progestogens on individual serum phospholipids and serum lecithin fatty acid composition.
Topics: Adult; Castration; Fatty Acids; Female; Humans; Levonorgestrel; Liver Function Tests; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Phosphatidylcholines; Phospholipids; Progesterone Congeners | 1982 |
Effect of medroxyprogesterone acetate and d-norgestrel on plasma renin activity, antidiuretic hormone, and urinary aldosterone in postmenopausal women.
Topics: Aged; Aldosterone; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norgestrel; Renin; Time Factors; Vasopressins | 1981 |
Postmenopausal hormone replacement therapy and plasma lipoproteins.
Topics: Aged; Cardiovascular Diseases; Cholesterol, HDL; Double-Blind Method; Drug Combinations; Estrogen Replacement Therapy; Estrogens; Female; Humans; Lipoproteins; Medroxyprogesterone Acetate; Middle Aged; Multicenter Studies as Topic; Norethindrone; Norethindrone Acetate; Norgestrel; Postmenopause; Progesterone Congeners; Progestins; Randomized Controlled Trials as Topic; Risk Factors | 1995 |
Estrogen replacement therapy in women with previously treated breast cancer. ACOG Committee Opinion: Committee on Gynecologic Practice Number 135-April 1994.
Topics: Adult; Breast Neoplasms; Case-Control Studies; Delayed-Action Preparations; DNA, Neoplasm; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Norgestrel; Postmenopause; Risk Factors; RNA, Neoplasm; Tamoxifen | 1994 |
Progestin regulation of vascular endothelial growth factor in human breast cancer cells.
Topics: Breast Neoplasms; Endometrial Neoplasms; Endothelial Growth Factors; Female; Gene Expression Regulation, Neoplastic; Humans; Lymphokines; Medroxyprogesterone Acetate; Megestrol Acetate; Mifepristone; Neoplasm Proteins; Neovascularization, Pathologic; Norethindrone; Norethynodrel; Norgestrel; Progesterone; Progestins; Receptors, Progesterone; Stimulation, Chemical; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1998 |
In vitro effect of estradiol, progesterone, testosterone, and of combined estradiol/progestins on low density lipoprotein (LDL) oxidation in postmenopausal women.
Topics: Copper Sulfate; Dose-Response Relationship, Drug; Estradiol; Female; Humans; Lipoproteins, LDL; Malondialdehyde; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norgestrel; Oxidation-Reduction; Postmenopause; Progesterone; Progesterone Congeners; Testosterone | 1998 |
Sixth fertility and sterility congress--a review.
Topics: Biology; Chlormadinone Acetate; Clomiphene; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Copper; Disease; Embolism; Endocrine System; Estrogens; Evaluation Studies as Topic; Family Planning Services; Hormones; Incidence; Infections; Injections; Intrauterine Devices; Medroxyprogesterone Acetate; Menstruation Disturbances; Norgestrel; Pelvic Inflammatory Disease; Physiology; Progesterone Congeners; Quinestrol; Research; Research Design; Therapeutics; Thromboembolism; Time; Uterine Perforation; Vascular Diseases; Zinc | 1968 |
Steroids.
Topics: Adrenal Cortex Hormones; Africa; Americas; Asia; Biology; Chlormadinone Acetate; Contraception; Contraceptives, Oral; Developed Countries; Developing Countries; Dimethisterone; Economics; Endocrine System; Estradiol; Ethynodiol Diacetate; Europe; Europe, Eastern; Family Planning Services; Germany, West; Hormones; Italy; Latin America; Medroxyprogesterone Acetate; Megestrol Acetate; Mestranol; Mexico; Netherlands; Norethindrone; Norethynodrel; Norgestrel; North America; Physiology; Progesterone; Progestins; Research; Switzerland; Technology; Testosterone; United Kingdom; United States | 1969 |
The relation of the structure of progestational steroids to nucleolar differentiation in human endometrium.
Topics: Biology; Cells; Chlormadinone Acetate; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Dimethisterone; Endocrine System; Endometrium; Ethynodiol Diacetate; Family Planning Services; Genitalia; Genitalia, Female; Histology; Hormones; In Vitro Techniques; Medroxyprogesterone Acetate; Norethindrone; Norethynodrel; Norgestrel; Physiology; Progesterone; Progestins; Research; Urogenital System; Uterus | 1972 |
Lipids and blood coagulation studies in women using steroidal hormones for contraception.
Topics: Biology; Blood; Blood Coagulation; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Family Planning Services; Fibrinolysis; Hemoglobins; Lipids; Medroxyprogesterone Acetate; Norgestrel; Physiology; Research; Statistics as Topic | 1972 |
[Gas chromatography of oral progestagens and estrogens].
Topics: Chlormadinone Acetate; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Dimethisterone; Ethinyl Estradiol; Family Planning Services; Lynestrenol; Medroxyprogesterone Acetate; Megestrol Acetate; Mestranol; Norethindrone; Norgestrel | 1968 |
[What happens in our patients' bodies to the steroid hormones we prescribe? 2. Synthetic progestins].
Topics: Chlormadinone Acetate; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Ethynodiol Diacetate; Family Planning Services; Lynestrenol; Medroxyprogesterone Acetate; Megestrol Acetate; Norethindrone; Norgestrel | 1981 |
Norelgestromin as selective estrogen enzyme modulator in human breast cancer cell lines. Effect on sulfatase activity in comparison to medroxyprogesterone acetate.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Ethisterone; Humans; Inhibitory Concentration 50; Medroxyprogesterone Acetate; Models, Chemical; Norgestrel; Oximes; Selective Estrogen Receptor Modulators; Sulfatases; Tumor Cells, Cultured | 2003 |
Norgestimate and medroxyprogesterone acetate do not attenuate the atheroprotective effects of 17beta-estradiol in ovariectomized, apolipoprotein E-deficient mice.
Topics: Adipose Tissue; Animals; Apolipoproteins E; Arteriosclerosis; Blood Glucose; Body Weight; Dose-Response Relationship, Drug; Estradiol; Female; Insulin; Lipids; Lipoproteins; Medroxyprogesterone Acetate; Mice; Mice, Knockout; Norgestrel; Organ Size; Ovariectomy; Random Allocation; Sinus of Valsalva | 2004 |
Clinical background of women prescribed tibolone or combined estrogen + progestogen therapies: a UK MediPlus study.
Topics: Breast Neoplasms; Drug Administration Schedule; Drug Therapy, Combination; Drug Utilization; Endometrial Neoplasms; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norgestrel; Norpregnenes; Practice Patterns, Physicians'; Registries; Retrospective Studies; Risk Factors; United Kingdom | 2004 |
Preventing repeat teen pregnancy: postpartum depot medroxyprogesterone acetate, oral contraceptive pills, or the patch?
Topics: Adolescent; Adult; Chi-Square Distribution; Child; Contraception Behavior; Contraceptive Agents, Female; Contraceptives, Oral; Drug Combinations; Ethinyl Estradiol; Female; Humans; Medroxyprogesterone Acetate; Norgestrel; Postpartum Period; Pregnancy; Pregnancy in Adolescence; Prospective Studies | 2007 |
Clinical inquiries. What hormonal contraception is most effective for obese women?
Topics: Contraceptive Agents, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Evidence-Based Medicine; Female; Humans; Medroxyprogesterone Acetate; Norgestrel; Obesity; Pregnancy; Pregnancy Rate; Risk Assessment | 2007 |
Establishment of an HPLC identification system for detection of counterfeit steroidal drugs.
Topics: Chromatography, High Pressure Liquid; Diethylstilbestrol; Estriol; Ethinyl Estradiol; Medroxyprogesterone Acetate; Methyltestosterone; Norgestrel; Progesterone; Quinestrol; Sensitivity and Specificity; Steroids; Testosterone Propionate | 2008 |
Contraceptive options for women in selected circumstances.
Topics: Adolescent; Adult; Anemia; Breast Diseases; Cardiovascular Diseases; Condoms; Contraception; Contraceptive Agents, Female; Contraindications; Desogestrel; Diabetes Mellitus; Drug Combinations; Drug Implants; Epilepsy; Ethinyl Estradiol; Female; Heart Valve Diseases; Humans; Hypertension; Inflammatory Bowel Diseases; Injections; Intrauterine Devices; Levonorgestrel; Liver Diseases; Lupus Erythematosus, Systemic; Medroxyprogesterone Acetate; Migraine Disorders; Norethindrone; Norgestrel; Obesity; Patient Preference; Pregnancy; Progestins; Stroke; Young Adult | 2010 |